Etretinate may work where acitretin fails.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9115918.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Acitretin (Ro 10-1670, Neotigason), a second-generation monoaromatic retinoid, is the main acid derivative and active metabolite of etretinate (Ro 10-9359, Tigason). Three patients who were unresponsive to treatment with acitretin but who responded to etretinate are reported. Twenty-nine patients in the U.K. are currently receiving etretinate on a named-patient basis. Possible explanations for the functional discrepancy between the two drugs are discussed.
Medical subject headings
- Acitretin
- Etretinate
- Hand Dermatoses
- Keratolytic Agents
- Skin Diseases